Quitterie Reynaud

Effect of one-year lumacaftor–ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients

Bastien Misgault, Eva Chatron, Quitterie Reynaud et al. · Journal of Cystic Fibrosis · 2020 · 67 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +13

Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2 years of treatment with ivacaftor in a real-world setting

D. Hubert, Clémence Dehillotte, À. Munck et al. · Journal of Cystic Fibrosis · 2017 · 59 citations

Life Sciences, Genetics, Pharmacotherapy +12

Reproductive health after thoracic transplantation: An ISHLT expert consensus statement

M. Kittleson, Ersilia M. DeFilippis, Catriona Bhagra et al. · The Journal of Heart and Lung Transplantation · 2022 · 54 citations · Full text

Medicine, Gynecology, Surgery +12

Pregnancy outcome in women with cystic fibrosis and poor pulmonary function

Quitterie Reynaud, Christine Rousset‐Jablonski, S. Poupon-Bourdy et al. · Journal of Cystic Fibrosis · 2019 · 49 citations · Full text

Medicine, Gynecology, Obstetrics +15

The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study

Pierre‐Régis Burgel, Isabelle Sermet‐Gaudelus, Emmanuelle Girodon et al. · The Lancet Respiratory Medicine · 2024 · 47 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12